Market cap: $4,231,658,540
Exchange: NAS
Sector: Health Technology
Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company. The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.
Company Name
Alpine Immune Sciences Inc
Average Volume (10 days)
2,192,425
Average Volume (30 days)
4,308,342
Moving Average (50 days)
$47.86
Moving Average (200 days)
$26.9
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
-131.4833
Market Cap
4,231,658,540
Shares Outstanding
65,546,136
52-Week High Split Adjust Only
64.7
52-Week Low Split Adjust Only
6.71
Employee Count
125
Beta
1.7577
Next Earnings Date
2024-05-09
TTM Dividend Rate Per Share
0
Past 5 days
0%
Past 30 days
0.67%
Past 3 months
1.57%
Past 6 months
5.94%
Past year
7.92%
Past 2 years
5.93%
Past 5 years
8.96%
Max % Change
0.08%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Alpine Immune Sciences Inc | ALPN | n/a | n/a | -7.7 | n/a | n/a |
| Peer Avg | N/A | 3.32 | -1.07 | -10.5 | 3.32 | 4.06 |
| Olema Pharmaceuticals Inc | OLMA | n/a | n/a | -21.2 | n/a | n/a |
| Omeros Corporation | OMER | 13.27 | -4.27 | -7.7 | 13.27 | 16.24 |
| Oncocyte Corporation | OCX | n/a | n/a | -13.1 | n/a | n/a |
| Oragenics Inc. | OGEN | n/a | n/a | n/a | n/a | n/a |